Device Trial Radar · NCT02864966
A 24 Hour Occlusive Single Patch Test to Assess Acute Tolerance of Pre Lubricated Condom on a Panel of Healthy Adult Subjects
Last checked: Nov 19, 2026Latest source record: Sep 9, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
33
Actual
Start
May 2016
Primary completion
May 2016
Study completion May 2016
Sponsor
- Lead sponsor
- Reckitt Benckiser Healthcare (UK) LimitedNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Alba Science Ltd
- First posted
- Aug 12, 2016
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a 24 hour patch test to determine the acute tolerance of 3 variants of condom on a panel of healthy adult subjects. The patches will be affixed to the back and remain under occlusion for 24 hours. They will then be assessed at 30 minutes and 24 hours post patch removal.
Conditions
- Healthy
Interventions
CondomDevice
This study involves testing a condom, however the device will not be used as intended. The device will be destroyed to make the test patches required for this safety study.
Primary outcomes
What the sponsor says the trial is designed to measure.
- The primary endpoint is the irritation of the test products according to the Cutaneous Irritancy Index value. The test products are expected to be graded as 'non-irritant' as confirmed by a dermatologist.Time frame: 24 hours
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Alba Science Ltd
Edinburgh, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.